Meabco A/S
- Country
- 🇩🇰Denmark
- Ownership
- Private
- Established
- 2001-09-17
- Employees
- 1
- Market Cap
- -
- Website
- http://www.meabco.com
Dose-finding Study of BP-C1 in Patients With Stage IV Breast Cancer
- First Posted Date
- 2020-03-06
- Last Posted Date
- 2020-03-06
- Lead Sponsor
- Meabco A/S
- Target Recruit Count
- 18
- Registration Number
- NCT04298333
- Locations
- 🇹ðŸ‡
Siriraj Hospital, Mahidol University, Bangkok, Thailand
🇨🇳National Taiwan University Hospital, Taipei, Taiwan
🇮🇩Sanglah University Hospital, Bali, Indonesia
BP-C1 Monotherapy in Patients With Metastatic Breast Cancer Cancer: Estimation of Optimal Duration of Treatment
- First Posted Date
- 2018-12-28
- Last Posted Date
- 2019-10-10
- Lead Sponsor
- Meabco A/S
- Target Recruit Count
- 29
- Registration Number
- NCT03789019
- Locations
- 🇹ðŸ‡
Lampang Cancer Hospital, Lampang, Thailand
🇷🇺St. Petersburg State Budgetary Health Organization, City Clinical Oncology Dispensary, St Petersburg, Russian Federation
🇹ðŸ‡Ubon Ratchanthani Cancer Hospital, Ubon Ratchathani, Thailand
BP-C1 in Short-term Treatment of Metastatic Pancreatic Cancer
- Conditions
- Metastatic Pancreatic CancerUnresectable Pancreatic Cancer
- Interventions
- First Posted Date
- 2018-08-13
- Last Posted Date
- 2018-11-15
- Lead Sponsor
- Meabco A/S
- Target Recruit Count
- 16
- Registration Number
- NCT03627390
- Locations
- 🇪🇬
National Liver Institute, Menoufia University, Cairo, Egypt
BP-C1 in Short-term Treatment of Thai Patients With Metastatic Breast Cancer
- Conditions
- Metastatic Breast CancerStage IV Breast Cancer
- Interventions
- Drug: Placebo
- First Posted Date
- 2018-07-27
- Last Posted Date
- 2019-10-07
- Lead Sponsor
- Meabco A/S
- Target Recruit Count
- 38
- Registration Number
- NCT03603197
- Locations
- 🇹ðŸ‡
Udon Thani Cancer Hospital, Udon Thani, Udon Thani Province, Thailand
🇹ðŸ‡Lampang Cancer Center, Lampang, Thailand
🇹ðŸ‡Siriraj Hospital, Mahidol University, Bangkok, Thailand
BP-C1 in Short-term Treatment of Patients With Metastatic Breast Cancer
- Conditions
- Metastatic Breast CancerStage IV Breast Cancer
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-05-26
- Last Posted Date
- 2019-10-10
- Lead Sponsor
- Meabco A/S
- Target Recruit Count
- 36
- Registration Number
- NCT02783794
- Locations
- 🇷🇺
Russian Oncological Research Centre n.a. N.N. Blokhin, Russian Academy of Medical Science (RAMS), Moscow, Russian Federation
🇷🇺Leningrad Regional Oncological Centre, St. Petersburg, Russian Federation
🇹ðŸ‡Udon Thani Cancer Hospital, Udon Thani, Thailand
BP-C1 in Metastatic Breast Cancer Patients
- First Posted Date
- 2013-05-23
- Last Posted Date
- 2019-10-07
- Lead Sponsor
- Meabco A/S
- Target Recruit Count
- 10
- Registration Number
- NCT01861509
- Locations
- 🇹ðŸ‡
Lampang Cancer Center, Lampang, Thailand
🇮🇱Oncology Unit. Sheba Medical Centre, Ramat-Gan, Israel